Mercer Global Advisors’s NuVasive, Inc. NUVA Stock Holding History

Mercer Global Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,505	Closed	-$236K	–	1959
2021 Q4	$236K	Sell	4,505 -53	-1%	-$2.88K	﹤0.01%	1583
2021 Q3	$273K	Sell	4,558 -1,819	-29%	-$112K	﹤0.01%	1473
2021 Q2	$432K	Buy	6,377 +17	+0.3%	+$1.16K	﹤0.01%	1212
2021 Q1	$417K	Buy	+6,360	New	+$381K	﹤0.01%	1160

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Mercer Global Advisors's NUVA Position: Q1 2022 in Review

Mercer Global Advisors sold out of NuVasive, Inc. (NUVA) in Q1 2022, closing a stake of 4,505 shares — an estimated $236K sold.

Mercer Global Advisors first reported a position in NUVA in Q1 2021 and held it in 4 quarters. The position peaked at $432K in Q2 2021. 245 funds tracked by Wall St. Rank hold NUVA as of Q1 2022.

Mercer Global Advisors reported no remaining NuVasive, Inc. position as of Q1 2022 after selling out during the quarter.
Mercer Global Advisors sold 4,505 NuVasive, Inc. shares in Q1 2022, an estimated $236K.
Mercer Global Advisors first reported a position in NuVasive, Inc. in Q1 2021 and held it in 4 quarters.
Mercer Global Advisors's NuVasive, Inc. position peaked at $432K in Q2 2021.
245 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2022.

Based on Mercer Global Advisors's 13F filing for Q1 2022, filed 10 May 2022.